Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) General Information

Description

The rights and control of fatty acid amide hydrolase technology. The portfolio consists of KDS-4103, a phase 1-ready compound under exclusive license from the University of California at Irvine, patents and the compound library including novel second generation FAAH inhibitors. Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that has been shown to catalyze the degradation of the fatty acid ethanolamide (FAE) family of endogenous signaling lipids, including the endogenous cannabinoid (CB) receptor agonist anandamide, thus terminating their effects.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 101 Theory
  • Suite 100
  • Irvine, CA 92617
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Organon BioSciences
Corporate Office
  • 101 Theory
  • Suite 100
  • Irvine, CA 92617
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS)‘s full profile, request access.

Request a free trial

Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS)‘s full profile, request access.

Request a free trial

Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) FAQs

  • Where is Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) headquartered?

    Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) is headquartered in Irvine, CA.

  • What industry is Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) in?

    Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS)’s primary industry is Buildings and Property.

  • Is Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) a private or public company?

    Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) is a Private company.

  • What is Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS)’s current revenue?

    The current revenue for Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) is .

  • Who are Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS)’s investors?

    Kadmus Pharmaceuticals has invested in Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS).

  • When was Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) acquired?

    Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) was acquired on 26-Jun-2007.

  • Who acquired Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS)?

    Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) was acquired by Organon BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process